Selection Guide,Antimicrobial peptides from hylid and ranin frogs

The constant threat of antibiotic resistance has spurred a global search for novel antimicrobial agents. In this quest, nature often provides the most ingenious solutions, and the humble frog stands out as a remarkable source of potent antimicrobial peptides (AMPs). These peptides, secreted from frog skin, represent a sophisticated defense mechanism developed over millions of years, offering a broad spectrum of activity against a diverse range of pathogens. Understanding the properties and potential applications of antimicrobial peptide frog secretions is crucial for developing next-generation antibiotics.

Frog skin AMPs are not just simple antibacterial agents; they are highly evolved molecules with a complex mode of action. Research consistently shows that these frog-derived synthetic peptides are highly potent against antibiotic-resistant bacteria, as well as protozoa, yeasts, and fungi. Their efficacy stems from their ability to directly interact with and disrupt the cell membranes of these microorganisms. Unlike traditional antibiotics that often target specific intracellular processes, AMPs primarily act by permeating and destroying the plasma membrane, making it significantly harder for pathogens to develop resistance. This direct attack mechanism is a key reason why scientists are so invested in studying antimicrobial peptides from frog skin.

The biodiversity of AMPs found in frogs is astounding. Different species possess unique peptide families, each with specific characteristics and target profiles. For instance, brevinins are a well-studied family of antimicrobial peptides identified in the skin of Ranidae frogs. A specific example, brevinin-1E-OG9, isolated from the skin secretions of *Odorrana grahami*, has demonstrated potent antimicrobial activity, particularly against *Staphylococcus* species. Similarly, temporins, another class of AMPs, are short peptides secreted by frogs globally and primarily exert their effects against Gram-positive bacteria. The literature also highlights AMPs like Odorranain-C1, an α-helical cationic antimicrobial peptide extracted from frog skin, which exhibits broad-spectrum antimicrobial activity.

The scientific community has made significant strides in not only isolating these natural compounds but also in synthesizing and modifying them for therapeutic use. Studies have focused on developing synthetic peptides that mimic the action of natural frog AMPs, often enhancing their stability and efficacy. For example, researchers have created synthetic peptides derived from frog secretions that display anti-infective activity against Gram-negative pathogens, with some showing activity in the range of 16 to 64 µmol l⁻¹. This synthetic approach allows for greater control over the peptide's properties and scalability for potential pharmaceutical applications.

Beyond their direct antibacterial effects, some frog skin peptides exhibit a wider range of beneficial activities. For example, research on the plateau frog peptide suggests roles in environmental adaptation, and some AMPs possess antimicrobial and anti-inflammatory effects. The frog skin-derived antimicrobial peptide (AMP) Esc(1–21) and its derivatives have shown potent *in vitro* antipseudomonal activity, indicating their potential in treating challenging infections. Furthermore, frog skin itself is recognized as a rich source of AMPs with broad-spectrum antimicrobial activity against strains of antibiotic-resistant bacteria and fungi, making them valuable for research into new therapeutic agents.

The evolutionary history of these peptides is also a fascinating area of study. Antimicrobial peptides from hylid and ranin frogs are believed to have originated from a common ancestral precursor dating back 150 million years, indicating a long-standing and crucial role in amphibian survival. These Skin-secreted peptides, generally considered part of the amphibian immune system, are continuously produced to protect the permeable amphibian skin from a constant barrage of environmental pathogens. Research indicates that Secreted AMPs protect amphibians against diverse skin pathogens, underscoring their importance in amphibian health.

The potential applications of antimicrobial peptide frog research extend beyond human medicine. While the focus is often on combating human infections, the inherent properties of these peptides suggest broader uses. For instance, some frog skin-derived peptides, like frenatin-2.1S and frenatin-2.2S, have demonstrated potent antimicrobial activity against clinical isolates of MRSA and *S. epidermidis*. Additionally, studies have found that certain frog skin peptides can have antifungal activity against Candida albicans and antibacterial effects against Staphylococcus aureus. This broad-spectrum activity makes them promising candidates for tackling a variety of microbial threats.

In summary, the study of antimicrobial peptide frog secretions is a vibrant and rapidly evolving field. From the diverse families of brevinins and temporins to novel peptides like brevinin-1E-OG9 and Odorranain-C1, these natural compounds offer a powerful arsenal against microbial infections. The ability to synthesize and modify these peptides further amplifies their therapeutic potential, providing a promising avenue for the development of new antibiotics in an era where such innovations are desperately needed. The **frogs